Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.26 EUR
−15.06 M EUR
0.00 EUR
3.95 M
About Monopar Therapeutics Inc.
Sector
Industry
CEO
Chandler Drew Robinson
Website
Headquarters
Wilmette
Founded
2014
ISIN
US61023L2079
FIGI
BBG00RVCW6G3
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1IY0 is 66.50 EUR — it hasn't changed in the past 24 hours. Watch Monopar Therapeutics Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Monopar Therapeutics Inc stocks are traded under the ticker 1IY0.
1IY0 stock has risen by 15.65% compared to the previous week, the month change is a 146.30% rise, over the last year Monopar Therapeutics Inc has showed a 1.35 K% increase.
We've gathered analysts' opinions on Monopar Therapeutics Inc future price: according to them, 1IY0 price has a max estimate of 110.75 EUR and a min estimate of 59.63 EUR. Watch 1IY0 chart and read a more detailed Monopar Therapeutics Inc stock forecast: see what analysts think of Monopar Therapeutics Inc and suggest that you do with its stocks.
1IY0 reached its all-time high on Sep 19, 2025 with the price of 57.50 EUR, and its all-time low was 2.01 EUR and was reached on Aug 29, 2024. View more price dynamics on 1IY0 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1IY0 stock is 1.53% volatile and has beta coefficient of 1.30. Track Monopar Therapeutics Inc stock price on the chart and check out the list of the most volatile stocks — is Monopar Therapeutics Inc there?
Today Monopar Therapeutics Inc has the market capitalization of 405.50 M, it has increased by 38.84% over the last week.
Yes, you can track Monopar Therapeutics Inc financials in yearly and quarterly reports right on TradingView.
Monopar Therapeutics Inc is going to release the next earnings report on Nov 7, 2025. Keep track of upcoming events with our Earnings Calendar.
1IY0 earnings for the last quarter are −0.30 EUR per share, whereas the estimation was −0.39 EUR resulting in a 23.64% surprise. The estimated earnings for the next quarter are −0.35 EUR per share. See more details about Monopar Therapeutics Inc earnings.
Monopar Therapeutics Inc revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
1IY0 net income for the last quarter is −2.08 M EUR, while the quarter before that showed −2.43 M EUR of net income which accounts for 14.16% change. Track more Monopar Therapeutics Inc financial stats to get the full picture.
No, 1IY0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 27, 2025, the company has 16 employees. See our rating of the largest employees — is Monopar Therapeutics Inc on this list?
Like other stocks, 1IY0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Monopar Therapeutics Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Monopar Therapeutics Inc technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Monopar Therapeutics Inc stock shows the strong buy signal. See more of Monopar Therapeutics Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.